Picard Medical, Inc. Form 8-K Summary
Business Context and Reporting Period
Picard Medical, Inc. (PMI), a Delaware corporation listed on the NYSE American, filed this Current Report on Form 8-K on July 21, 2026. The filing addresses a corporate action regarding the Company's capital structure.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a corporate governance event.
Material Changes
The Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a reverse stock split of its Common Stock at a ratio of 1-for-50. Key details include:
- Effective Time: 5:00 PM Eastern Time on July 31, 2026.
- Trading Resumption: August 3, 2026, on a split-adjusted basis under the existing symbol "PMI".
- Share Calculation: Every 50 shares will be combined into one share. Fractional shares will not be issued; resulting numbers are rounded up to the nearest whole share.
- Par Value: Remains unchanged at $0.0001 per share.
- New CUSIP: 71953R 207.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future operations, or specific risk factors beyond the mechanics of the stock split. The primary purpose is to notify shareholders of the impending change in share count and trading parameters.
Investor Verification Checklist
- Confirm the 1-for-50 reverse stock split ratio and the July 31, 2026 effective time.
- Verify the new CUSIP number (71953R 207) for trading purposes.
- Check brokerage account statements on or after August 3, 2026, to ensure shares are adjusted correctly and no fractional shares were mishandled.
- Review the press release (Exhibit 99.1) for any additional details on the rationale for the split.